Intervention Review

Oral paliperidone for schizophrenia

  1. Abraham M Nussbaum1,*,
  2. T S Stroup2

Editorial Group: Cochrane Schizophrenia Group

Published Online: 23 APR 2008

Assessed as up-to-date: 11 NOV 2008

DOI: 10.1002/14651858.CD006369.pub2

How to Cite

Nussbaum AM, Stroup TS. Oral paliperidone for schizophrenia. Cochrane Database of Systematic Reviews 2008, Issue 2. Art. No.: CD006369. DOI: 10.1002/14651858.CD006369.pub2.

Author Information

  1. 1

    Denver Health, Behavioral Health Service, Denver, CO, USA

  2. 2

    Columbia University, Psychiatry, New York, New York, USA

*Abraham M Nussbaum, Behavioral Health Service, Denver Health, MC 0490, 777 Bannock Street, Denver, CO, 80204, USA.

Publication History

  1. Publication Status: Edited (no change to conclusions), comment added to review
  2. Published Online: 23 APR 2008


Cited in:


This article has been cited by:

  1. 1
    Mark Viron, Travis Baggett, Michele Hill, Oliver Freudenreich, Schizophrenia for Primary Care Providers: How to Contribute to the Care of a Vulnerable Patient Population, The American Journal of Medicine, 2012, 125, 3, 223


  2. 2
    Tinggang Chang, Wenyu Hsu, Siseng Huang, Nanying Chiu, Yicheng Liao, Augmentation of clozapine with paliperidone in treatment-resistant schizophrenia-A case series, Acta Neuropsychiatrica, 2011, 23, 1
  3. 3
    Abraham M Nussbaum, T S Stroup, Oral paliperidone for schizophrenia, The Cochrane Library,